Gastrointestinal symptoms among study subjects
| All Patients (136) n (%) | Patients with positive nasopharyngeal swab SARS-CoV-2 (120) n (%) | Patients with positive anal swab SARS-CoV-2 (45) n (%) | |
| Gastrointestinal symptoms, n (%) | 92 (67.6) | 81 (67.5) | 33 (73.3) |
|
Anorexia
Bloated stomach Diarrhoea Constipation Nausea Vomiting Abdominal pain | 63 (46.3) 26 (19.1) 17 (12.5) 4 (2.9) 64 (47) 21 (15.4) 28 (20.6) | 56 (46.7) 24 (20) 15 (12.5) 3 (2.5) 58 (48.3) 19 (15.8) 25 (20.8) | 24 (53.3) 11 (24.4) 8 (17.8) 0 (0) 25 (55.6) 8 (17.8) 9 (20) |